| Entry ID |
Original Release date |
Data summary |
Entry Title |
Citation Title |
Authors |
Additional Matches |
| 7396 |
2008-06-17 |
Chemical Shifts: 1 set
|
Solution Structure of ETO-TAFH refined in explicit solvent |
A TAF4-homology domain from the corepressor ETO is a docking platform for positive and negative regulators of transcription
|
C Woodrell, J Lausen, M H Werner, N Biris, N Kobayashi, S Cho, S Liu, S Yokoyama, Y Wei | |
| 7147 |
2006-10-30 |
Chemical Shifts: 1 set
|
The acute myeloid leukemia fusion protein AML1-ETO targets E-proteins via a PAH-like TAFH domain |
The acute myeloid leukemia fusion protein AML1-ETO targets E proteins via a paired amphipathic helix-like TBP-associated factor homology domain
|
C Guo, J Zhang, M Ikura, M J Plevin, R G Roeder | |
| 5662 |
2004-03-15 |
Chemical Shifts: 1 set
|
Distinctive solution conformation of phosphatase inhibitor CPI-17 substituted with aspartate at the phosphorylation site threonine |
Distinctive solution conformation of phosphatase inhibitor CPI-17 substituted with aspartate at the phosphorylation-site threonine residue.
|
D L Brautigan, M Eto, M Kainosho, M Shimizu, R Takada, S Ohki | |
| 5663 |
2004-03-15 |
Chemical Shifts: 1 set
|
Distinctive solution conformation of phosphatase inhibitor CPI-17 substituted with aspartate at the phosphorylation site threonine |
Distinctive solution conformation of phosphatase inhibitor CPI-17 substituted with aspartate at the phosphorylation-site threonine residue.
|
D L Brautigan, M Eto, M Kainosho, M Shimizu, R Takada, S Ohki | |
| 15161 |
2007-10-24 |
Chemical Shifts: 1 set
|
The MYND domain from human AML1-ETO |
Structural basis for recognition of SMRT/N-CoR by the MYND domain and its contribution to AML1/ETO's activity
|
John Bushweller, Justin Gaudet, Kari Hartman, Liya Roudaia, Matthew Cheney, Nancy Speck, Rachel Klet, Thomas Laue, Tomasz Cierpicki, Wei Chen, Yizhou Liu | Assembly name: ETO MYND |
